Related Experiment Video
Updated: May 2, 2026
06:23
The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
Published on: October 13, 2016
36.6K
[Depression or Alzheimer-type dementia?].
Martin Bystad1, Karin Pettersen2, Ole Kristian Grønli2
1Alderspsykiatrisk avdeling Universitetssykehuset Nord-Norge og Institutt for psykologi Universitetet i Tromsø
Summary
Distinguishing depression from Alzheimer-type dementia in the elderly is challenging due to overlapping symptoms. Clinical assessment, including disease progression and cognitive screening, aids diagnosis.
Area of Science:
- Geriatric Medicine
- Neurology
- Psychiatry
Context:
- Increasing prevalence of depression and Alzheimer-type dementia in the elderly population.
- Shared symptoms between depression and Alzheimer-type dementia complicate differential diagnosis.
- Co-occurrence of both conditions in the same patient presents diagnostic challenges.
Purpose:
- To provide an overview of key symptoms and findings for differentiating depression from Alzheimer-type dementia.
- To guide clinicians in distinguishing between these two prevalent elderly conditions.
- To highlight diagnostic strategies for accurate identification of depression versus Alzheimer-type dementia.
Summary:
- Depression and Alzheimer-type dementia share cognitive and affective symptoms like amnesia, attention deficits, and lack of initiative.
- Disease progression, daily functioning, collateral information from family, neuropsychological tests, biomarkers, and neuroimaging are crucial for differentiation.
- General practitioners can diagnose these conditions using clinical assessment, patient history, and cognitive screening, referring complex cases to specialists.
Impact:
- Improved diagnostic accuracy for depression and Alzheimer-type dementia in elderly patients.
- Facilitates timely and appropriate treatment interventions for affected individuals.
- Enhances clinical decision-making for primary care physicians and specialists in geriatric mental health.
Related Concept Videos
01:22Dementia l: Introduction
35
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
35
01:29Alzheimer Disease l: Introduction
21
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
21
01:30Dementia
687
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
687
01:26Alzheimer's Disease: Overview
1.7K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.7K
01:23Alzheimer Disease ll: Pathophysiology
35
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and...
35
01:22Alzheimer's Disease: Treatment
1.3K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.3K